Autek China Inc. (SHE:300595)
15.24
+0.07 (0.46%)
May 13, 2025, 3:04 PM CST
Autek China Revenue
Autek China had revenue of 478.21M CNY in the quarter ending March 31, 2025, with 2.95% growth. This brings the company's revenue in the last twelve months to 1.83B, up 1.50% year-over-year. In the year 2024, Autek China had annual revenue of 1.81B with 4.40% growth.
Revenue (ttm)
1.83B
Revenue Growth
+1.50%
P/S Ratio
7.47
Revenue / Employee
510.42K
Employees
3,580
Market Cap
13.66B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.81B | 76.44M | 4.40% |
Dec 31, 2023 | 1.74B | 211.85M | 13.89% |
Jan 1, 2023 | 1.53B | 230.27M | 17.78% |
Jan 1, 2022 | 1.30B | 424.38M | 48.74% |
Dec 31, 2020 | 870.66M | 223.76M | 34.59% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |